Men's Health Archive

Most men with prostate cancer have low-grade cancer, meaning the cancer is unlikely to spread or affect quality of life or longevity. But men whose initial prostate biopsy shows an intermediate-risk or high-risk cancer, or those who began active surveillance for low-risk cancer but develop a rising PSA or new symptoms suggesting aggressive cancer, have several treatment options available. These include different combinations of radiation, surgery, androgen deprivation therapy, chemotherapy, immunotherapy, and anti-androgens.

Looking after a loved one who has prostate cancer can be overwhelming. Caregivers play crucial roles in supporting a patient's physical and psychological well-being. But what does that entail? Here's what to know about effective communication, day-to-day support, and taking care of yourself.

Erectile dysfunction pills have helped millions of men continue to enjoy an active sex life. However, they may not work for all men, and others may not like being dependent on the medication or are bothered by side effects, such as headaches, flushing, upset stomach, or dizziness. In these cases, men may benefit from nondrug options, such as increasing aerobic exercise, adopting a plant-based diet, performing Kegel exercises, and using sexual aids that help them get and keep erections.

Most men over 50 will develop an enlarged prostate. Many different therapies are available, including medications and various types of surgery. Aquablation is gaining in popularity, and a recent study showed that improvements in urinary function from aquablation were still holding up after five years.

Dripping urine after going to the bathroom is common as men age, but a simple "milking" technique can help prevent this.

Roughly one in six men will be diagnosed with prostate cancer at some point in their lives, but these cancers usually aren't life-threatening. The least risky form of the disease occurs frequently with age, will not metastasize to other parts of the body, and it doesn't require any immediate treatment. So, should it even be called cancer?

Researchers are developing tools for predicting how fast prostate cancer might progress; among the most promising are those that count circulating tumor cells (CTCs) in blood samples. Research shows that high CTC counts predict poorer survival and faster disease progression. But they are also predictive for early-stage metastatic prostate cancer that still responds to hormonal therapy.

A 2024 study suggests that men who follow active surveillance for their low-grade prostate cancer may reduce the risk of their cancer becoming more aggressive if they maintain a healthier diet, which can help reduce inflammation.